XML 13 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting
9 Months Ended
Sep. 30, 2013
Segment Reporting [Abstract]  
Segment Reporting
11. Segment Reporting. The Company has five reportable segments: Apex, Oxford, Life Sciences, Physician, and Healthcare. The Company’s management evaluates the performance of each segment primarily based on revenues, gross profit and operating income. The information in the following table is derived directly from the segments’ internal financial reporting used for corporate management purposes.

The following table presents revenues, gross profit and operating income by reportable segment (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2013
 
2012
 
2013
 
2012
Revenues:
 
 
 
 
 
 
 
Apex
$
246,369

 
$
202,664

 
$
692,543

 
$
301,167

Oxford
100,005

 
88,104

 
296,741

 
254,970

Life Sciences
44,124

 
40,646

 
126,474

 
122,506

Physician
26,223

 
27,479

 
78,991

 
76,607

Healthcare
15,450

 
15,618

 
44,538

 
41,884

 
$
432,171

 
$
374,511

 
$
1,239,287

 
$
797,134

Gross Profit:
 
 
 
 
 
 
 
Apex
$
69,448

 
$
56,934

 
$
188,963

 
$
83,917

Oxford
34,660

 
31,250

 
101,316

 
90,266

Life Sciences
14,306

 
14,002

 
41,528

 
41,649

Physician
7,382

 
8,370

 
22,505

 
23,587

Healthcare
4,820

 
5,075

 
14,145

 
13,498

 
$
130,616

 
$
115,631

 
$
368,457

 
$
252,917

Operating Income (Loss):
 
 
 
 
 
 
 
Apex
$
20,021

 
$
13,204

 
$
46,531

 
$
9,556

Oxford
14,084

 
13,251

 
39,509

 
36,007

Life Sciences
2,146

 
3,020

 
4,093

 
8,291

Physician
1,416

 
3,207

 
5,497

 
6,269

Healthcare
(779
)
 
(1,154
)
 
(2,170
)
 
(3,745
)
 
$
36,888

 
$
31,528

 
$
93,460

 
$
56,378


The Company operates internationally, with operations mainly in the United States, Europe, Canada, Australia and New Zealand. The following table presents domestic and foreign revenues (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2013
 
2012
 
2013
 
2012
Revenues:
 
 
 
 
 
 
 
Domestic
$
411,817

 
$
354,831

 
$
1,179,417

 
$
739,150

Foreign
20,354

 
19,680

 
59,870

 
57,984

 
$
432,171

 
$
374,511

 
$
1,239,287

 
$
797,134


 
The Company does not report Life Sciences and Healthcare segments’ total assets separately as the field operations are largely combined. The following table presents total assets as allocated by reportable segment (in thousands):

 
September 30, 2013
 
December 31, 2012
Total Assets:
 
 
 
Apex
$
664,284

 
$
642,594

Oxford
240,911

 
231,211

Life Sciences and Healthcare
132,008

 
139,601

Physician
81,279

 
84,615

 
$
1,118,482

 
$
1,098,021